Early Postoperative L-arginine and Acute Kidney Injury After Cardiac Surgery
NCT07718373 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-08-10
Summary
Acute kidney injury (AKI) is common after cardiac surgery, yet effective protective strategies remain limited. L-arginine is the substrate for endogenous nitric oxide (NO) synthesis and may improve renal perfusion and endothelial function. investigators emulated a target trial to evaluate whether early perioperative L-arginine was associated with a lower risk of AKI after cardiac surgery.
Conditions
Interventions
- DRUG
-
L-arginine
Initiation of L-arginine within 3 postoperative days
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-20
- Primary Completion
- 2026-08-20
- Completion
- 2026-08-20
More Related Trials
-
Vascular Interaction With Age in Myocardial Infarction
NCT00051376 ·Status: COMPLETED ·Phase: NA
-
Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
NCT00345150 ·Status: COMPLETED ·Phase: PHASE1
-
L-citrulline Supplementation During Sepsis
NCT00628381 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure
NCT00344734 ·Status: COMPLETED ·Phase: PHASE1
-
Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury
NCT02882373 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Add-on L-Arginine Therapy on Heart Failure Patients
NCT07394270 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Role of L-arginine in the Endothelial Dysfunction
NCT00583388 ·Status: WITHDRAWN
-
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 ·Status: COMPLETED ·Phase: NA
-
Prospective L-arginine Study
NCT01485757 ·Status: TERMINATED ·Phase: PHASE1
-
Dose-response Study of Arginine Supplementation in Severe Sepsis
NCT01775020 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
L-Arginine Metabolism in Essential Hypertension
NCT00137124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of a Dietary Supplement on Exercise Performance in Healthy Older Adults"
NCT01073332 ·Status: COMPLETED ·Phase: NA
-
Renal Hemodynamics and Tubular Function in Patients With Obstructive Sleep Apnea and Healthy Controls
NCT00410085 ·Status: COMPLETED ·Phase: PHASE4
-
Glomerular Injury of Preeclampsia
NCT00275158 ·Status: COMPLETED ·Phase: NA
-
L-Arginine in Pre-Eclampsia
NCT00157521 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Citrulline and Arginine Supplementation on the Post-exercise Hypotension (PEH)
NCT03378596 ·Status: UNKNOWN ·Phase: NA
-
L-arginine Treatment in Mild Hypertension
NCT02894723 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation
NCT01682889 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
NCT00005107 ·Status: UNKNOWN ·Phase: PHASE1
-
L-Arginine, Vascular Response and Mechanisms
NCT01482247 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
NCT03679780 ·Status: COMPLETED ·Phase: PHASE1
-
Endothelial Function in Human Arteries
NCT00848302 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
EFFECTS OF L-ARGININE SUPPLEMENTATION ON THE RECOVERY OF CARDIORESPIRATORY PARAMETERS AFTER SUBMAXIMAL EXERCISE TEST
NCT06405477 ·Status: RECRUITING ·Phase: NA
-
Effect of Creatine and L-Arginine on Endothelial Function
NCT00551434 ·Status: COMPLETED ·Phase: NA
-
Arginase Inhibition in Ischemia-reperfusion Injury
NCT02009527 ·Status: COMPLETED ·Phase: PHASE1